816 filings
Page 4 of 41
8-K
26vpltzum5watjnl
14 Feb 23
Soligenix Receives Refusal to File Letter from U.S. FDA for HyBryte™ New Drug Application in the Treatment of Cutaneous T-Cell Lymphoma
7:46am
8-K
v662hv
9 Feb 23
Soligenix Announces Reverse Stock Split
7:45am
DEFA14A
jg7mmqs
11 Jan 23
Additional proxy soliciting materials
8:02am
8-K
tesv0qpgj
11 Jan 23
Other Events
8:00am
8-K
uo40n5pv
27 Dec 22
Soligenix Announces Distribution of Series D Preferred Stock to Holders of its Common Stock
4:25pm
8-A12G
nuqn7d89 icjkwoedk
27 Dec 22
Registration of securities
4:05pm
8-K
hbkpbk4o7w9
23 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
i721ccmwv5h4aokxu
19 Dec 22
Other Events
8:00am
8-K
nrq7rf5 pk3a
15 Dec 22
Soligenix Announces Submission of New Drug Application to the FDA for HyBryte™ in the Treatment of Cutaneous T-cell Lymphoma
8:14am
8-K
mrhrpmmb kg8cx9l
18 Nov 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:45pm
DEFA14A
0xq3t k3mmmo
16 Nov 22
Additional proxy soliciting materials
4:57pm
DEFA14A
rr6gu y97exg
15 Nov 22
Additional proxy soliciting materials
4:02pm
DEFA14A
yxpma7lv
14 Nov 22
Additional proxy soliciting materials
7:54am
DEFA14A
toepxogz5dc5oihx5r
9 Nov 22
Additional proxy soliciting materials
5:13pm
S-8
tb52ro ybpuv2kgh
28 Oct 22
Registration of securities for employees
4:18pm
8-K
p15jecp7qmib0z
27 Oct 22
Soligenix Invited to Submit BARDA Contract Proposal for Development of Thermostabilized Subunit Vaccines for Sudan Ebola and Marburg Viruses
4:01pm
8-K
6qazzxb8y
25 Oct 22
Soligenix Announces Formation of Psoriasis
4:01pm